Thu Nov 07 11:42:18 UTC 2024: ## New Hope for Cancer Treatment: Scientists Identify Rogue DNA Fragments as Potential Targets

**New Haven, CT** – A groundbreaking study led by US and UK scientists has identified a novel approach to tackling some of the most aggressive forms of cancer, offering a potential breakthrough in treatment. The research, published in the journal *Nature Genetics*, focuses on extrachromosomal DNA (ecDNA), small loops of genetic material that play a crucial role in tumor growth and resistance to chemotherapy.

The study, which analyzed data from nearly 15,000 UK cancer patients across 39 different tumor types, revealed that over 16% of these cancers exhibited ecDNA. This discovery sheds light on how ecDNA drives cancer progression and resistance.

The researchers found that ecDNA is particularly prevalent in cancers that have become resistant to traditional therapies, such as taxol-based treatments. They also observed that ecDNA is prone to rapid mutations, which could explain why cancer becomes more aggressive and difficult to treat over time.

The study’s findings are significant because they have identified a potential target for new therapies. The research team is currently exploring a drug candidate that has the potential to selectively eliminate cancer cells containing ecDNA, preventing the rapid development of drug resistance.

“Our research suggests that ecDNA helps tumors become more aggressive,” said Dr. Roel Verhaak, senior author of the paper and Professor of Neurosurgery at Yale School of Medicine. “This distinct mechanism plays an important role not just for breast or lung cancer, but across many cancer types.”

Early-stage clinical trials are already underway to evaluate the efficacy of this promising drug candidate. If successful, it could significantly improve outcomes for patients with aggressive forms of cancer.

“We want to find vulnerabilities in tumors that have ecDNA,” said Verhaak. “EcDNA-targeting therapies could benefit as many as a third of all cancer patients.”

This research represents a major step forward in the fight against cancer, offering a new avenue for treatment and potentially changing the landscape of cancer care in the years to come.

Read More